Cough syrup deaths overseas prompts US crackdown on toxic testing

The U.S. FDA is cracking down on lax testing practices by dozens of makers of healthcare products following hundreds of deaths overseas from contaminated cough syrups, a Reuters review of regulatory alerts found. The Food and Drug Administration has reprimanded at least 28 companies this year, saying they failed to prove sufficient testing of ingredients used in over-the-counter drugs and consumer products for the toxins ethylene glycol (EG) and diethylene glycol (DEG), according to a Reuters analysis of agency import alerts and warning letters to manufacturers.

Related Keywords

India , United States , New York , Switzerland , Seoul , Soult Ukpyolsi , South Korea , Massachusetts , Canada , Indonesia , Usuhan , Cholla Bukto , Washington , Egypt , Hyderabad , Andhra Pradesh , Joyce Lee , Paul Hastings , Sangleaf Pharma , Rishika Sadam , Patrick Wingrove , Michele Gershberg , Charlene Paz , Greg Landry , Peter Lindsay , Drug Administration , Reuters , Massachusetts College Of Pharmacy Health Sciences , Suhan Aerosol , Daxal Therapeutics , Skyline Herbals , Massachusetts College , Health Sciences , Bill Berkrot , Healthcare Products , Consumer Products , Fda , Manufacturers , Testing Practices , Harmaceutical Grade Ingredients , Contamination , Orchid Lifesciences ,